Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$641M |
| 2 |
Apple
AAPL
|
+$468M |
| 3 |
Amazon
AMZN
|
+$459M |
| 4 |
Meta Platforms (Facebook)
META
|
+$238M |
| 5 |
Equinix
EQIX
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.25B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$135M |
| 3 |
JD.com
JD
|
+$56M |
| 4 |
VRNT
Verint Systems
VRNT
|
+$52.2M |
| 5 |
PRSP
Perspecta Inc. Common Stock
PRSP
|
+$50.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.31% |
| 2 | Financials | 13.64% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Communication Services | 9.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Ecovyst
ECVT
$1.2B
| $109K | ﹤0.01% |
7,034
+740
| +12% | +$11.7K |
|
2702
NRC Health Common Stock
NRC
$431M
| $109K | ﹤0.01% |
2,356
-94
| -4% | -$4.47K |
|
2703
Privia Health
PRVA
$2.77B
| $109K | ﹤0.01% |
+2,445
| New | +$90.2K |
|
|
GTHX
2704
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $109K | ﹤0.01% |
4,936
-100
| -2% | -$2.22K |
|
|
TIXT
2705
DELISTED
TELUS International
TIXT
| $108K | ﹤0.01% |
+3,475
| New | +$104K |
|
|
ARCH
2706
DELISTED
Arch Resources, Inc.
ARCH
| $108K | ﹤0.01% |
1,903
-314
| -14% | -$16.4K |
|
2707
Advantage Solutions
ADV
$337M
| $107K | ﹤0.01% |
+397
| New | +$123K |
|
2708
i3 Verticals
IIIV
$429M
| $107K | ﹤0.01% |
3,522
+1,494
| +74% | +$47.4K |
|
2709
PMV Pharmaceuticals
PMVP
$62.9M
| $107K | ﹤0.01% |
3,126
+1,697
| +119% | +$56.7K |
|
|
KLRS
2710
Kalaris Therapeutics
KLRS
$99.7M
| $107K | ﹤0.01% |
236
+69
| +41% | +$35.6K |
|
2711
Cue Biopharma
CUE
$113M
| $106K | ﹤0.01% |
304
-12
| -4% | -$4.65K |
|
|
DX
2712
Dynex Capital
DX
$3.18B
| $106K | ﹤0.01% |
5,707
+897
| +19% | +$17.6K |
|
2713
Arrow Financial
AROW
$661M
| $105K | ﹤0.01% |
3,187
| – | – |
|
2714
Ribbon Communications
RBBN
$376M
| $105K | ﹤0.01% |
13,751
-1,234
| -8% | -$9.44K |
|
|
CAI
2715
DELISTED
CAI International, Inc.
CAI
| $105K | ﹤0.01% |
1,888
-45
| -2% | -$2K |
|
|
AFMD
2716
DELISTED
Affimed
AFMD
| $104K | ﹤0.01% |
1,231
| – | – |
|
2717
Frontline
FRO
$8.81B
| $104K | ﹤0.01% |
11,504
+122
| +1% | +$982 |
|
2718
Independent Bank Corp
IBCP
$793M
| $104K | ﹤0.01% |
4,778
| – | – |
|
|
RFP
2719
DELISTED
Resolute Forest Products Inc.
RFP
| $104K | ﹤0.01% |
8,492
-6,471
| -43% | -$90.7K |
|
2720
Arcutis Biotherapeutics
ARQT
$3.31B
| $103K | ﹤0.01% |
3,783
-550
| -13% | -$15.5K |
|
2721
Anterix
ATEX
$1.96B
| $103K | ﹤0.01% |
1,716
-253
| -13% | -$12.7K |
|
2722
QCR Holdings
QCRH
$1.71B
| $103K | ﹤0.01% |
2,134
-192
| -8% | -$9.18K |
|
|
FLIC
2723
DELISTED
First of Long Island Corp
FLIC
| $102K | ﹤0.01% |
4,800
| – | – |
|
2724
Legend Biotech
LEGN
$3.73B
| $102K | ﹤0.01% |
2,479
-815
| -25% | -$27.7K |
|
2725
Alaunos Therapeutics
TCRT
$4.86M
| $102K | ﹤0.01% |
255
-13
| -5% | -$6.07K |
|
Similar funds
Legal & General Group's Q2 2021 Portfolio in Review
As of Q2 2021, Legal & General Group held 3,799 positions worth $299B, up 11% from $268B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Legal & General Group deployed $9.01B of net new capital in Q2 2021, opening 278 new positions and adding to 1,357 existing holdings. Its largest new stake was DoorDash: 333,886 shares worth $59.5M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alibaba, an estimated $2.25B trimmed.
- Legal & General Group's largest Q2 2021 buy was DoorDash: 333,886 shares worth $59.5M.
- Legal & General Group added most to Microsoft in Q2 2021, an estimated $641M increase.
- Legal & General Group's biggest Q2 2021 reduction was Alibaba, cutting an estimated $2.25B.
- Legal & General Group fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $135M.
- Legal & General Group's ten largest holdings make up 21% of its $299B portfolio in Q2 2021.
- Legal & General Group opened 278 new positions and closed 320 in Q2 2021.
- Legal & General Group's portfolio value rose 11% quarter-over-quarter to $299B.
Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.